Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2022-04-04 00:00:00 ET · period of report 2022-03-31 · accession 0000899243-22-013489 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | 2022-03-31 | BEAM | Ciaramella Giuseppe | Pres, CSO | S - Sale | $59.11 | -1,859 | 115.6K | -2% | -$109.9K | |
| 2022-04-04 | 2022-03-31 | BEAM | Ciaramella Giuseppe | Pres, CSO | A - Grant | $0.00 | +15.0K | 117.5K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | S | D | 1,859 | $59.11 | 115,614 | D | — | — | (F2) These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain RSUs. |
| 2 | Common | Common Stock | 2022-03-31 | A | A | 15,000 | $0.00 | 117,473 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with the Company through each vesting date. |